FEATURED ARTICLES

thINc360 PBM 2.0 Market Insight Panel; Taming the Prescription Drug Beast and Driving a Paradigm Shift with Alignment and Technology
thINc360 PBM 2.0 Market Insight Panel; Taming the Prescription Drug Beast and Driving a Paradigm Shift with Alignment and Technology

On May 23, 2022, Capital Rx’s Chief Growth Officer, Kristin Begley, was joined by an exceptional panel of experts on stage at thINc360.

Read
Capital Rx Closes $106M Series C to Improve Prescription Management and Healthcare Infrastructure
Capital Rx Closes $106M Series C to Improve Prescription Management and Healthcare Infrastructure

Capital Rx's JUDI™ Enterprise Pharmacy Platform modernizes prescription and healthcare infrastructure to power the 21st century of care delivery

Read
As Feds Probe Pharma’s Middlemen, Capital Rx Raises $106 Million For Software-Driven Fix
As Feds Probe Pharma’s Middlemen, Capital Rx Raises $106 Million For Software-Driven Fix

Thank you to Forbes’ Katie Jennings for expertly summarizing the challenges consumers face as a result of rising drug prices, as well as how Capital Rx’s $106M Series C funding will help accelerate the company's mission.

Read
The Consolidated Appropriations Act & Prescription Drug Data Collection (RxDC): New Rules & Regulations Equal New Responsibilities
The Consolidated Appropriations Act & Prescription Drug Data Collection (RxDC): New Rules & Regulations Equal New Responsibilities

The Consolidated Appropriations Act of 2021 (CAA) established protections for consumers related to surprise billing and transparency in healthcare. The goal of the Act is consistent with the federal government’s desire to reduce the inflation of healthcare spending by giving a clearer line of sight into a variety of opaque healthcare cost drivers, including those that have driven persistent inflation in pharmacy cost trend for plan sponsors.

Read